BETTER MAB

Serial Number 85482864
606

Registration Progress

Application Filed
Nov 29, 2011
Under Examination
Dec 25, 2012
Approved for Publication
Oct 30, 2012
Published for Opposition
Oct 30, 2012
Registered

Trademark Image

BETTER MAB

Basic Information

Serial Number
85482864
Filing Date
November 29, 2011
Published for Opposition
October 30, 2012
Abandonment Date
February 1, 2016
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 1, 2016
Classes
001 005 040 042
+2 more

Rights Holder

Intrexon Corporation

03
Address
1872 Pratt Drive, Suite 1400
Blacksburg, VA 24060

Ownership History

Intrexon Corporation

Original Applicant
03
Blacksburg, VA

Intrexon Corporation

Owner at Publication
03
Blacksburg, VA

Legal Representation

Attorney
David L. May

USPTO Deadlines

All Deadlines Cleared

All 8 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

50 events
Date Code Type Description Documents
Feb 1, 2016 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 1, 2016 MAB6 O ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED Loading...
Jul 9, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 8, 2015 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jun 23, 2015 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 23, 2015 EXT5 S SOU EXTENSION 5 FILED Loading...
Dec 16, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 15, 2014 EX4G S SOU EXTENSION 4 GRANTED Loading...
Dec 11, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 11, 2014 EXT4 S SOU EXTENSION 4 FILED Loading...
Jun 3, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 2, 2014 EX3G S SOU EXTENSION 3 GRANTED Loading...
May 28, 2014 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 28, 2014 EXT3 S SOU EXTENSION 3 FILED Loading...
Jan 31, 2014 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 30, 2014 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jan 24, 2014 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 24, 2014 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 4, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 4, 2013 EXT2 S SOU EXTENSION 2 FILED Loading...
Jun 20, 2013 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 18, 2013 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 18, 2013 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 18, 2013 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 25, 2012 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 30, 2012 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 30, 2012 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 10, 2012 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 21, 2012 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Sep 20, 2012 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Sep 20, 2012 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Sep 20, 2012 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Sep 20, 2012 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Sep 20, 2012 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 7, 2012 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 7, 2012 GNRT O NON-FINAL ACTION E-MAILED Loading...
Sep 7, 2012 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Sep 4, 2012 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Aug 26, 2012 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Aug 10, 2012 ALIE A ASSIGNED TO LIE Loading...
Aug 10, 2012 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jul 27, 2012 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 27, 2012 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Jul 27, 2012 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Jul 27, 2012 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Jul 27, 2012 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jul 20, 2012 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 19, 2012 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 19, 2012 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 14, 2012 CNRT R NON-FINAL ACTION WRITTEN Loading...

Detailed Classifications

Class 001
Chemicals, biochemicals and reagents for use in industry and science; Chemicals for use in biochemical and chemical industry; chemicals for use in agriculture; chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations for scientific purposes; chemical reagents for non-medical purposes; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting cellular activity or gene expression, ligands, genetic vectors, genetic hosts, genetic biochemicals, genetic bioengineering reagents and proteins for use in modifying and regulating cellular functions in transgenic plants, fungi and animals, and in cells of plants, fungi and animals; antibodies for scientific and research use; antibodies for regulating, modifying or regulating cellular functions in plants, fungi and animals, and in cells of plants, fungi and animals; kits consisting primarily of proteins for regulating, modifying or restricting cellular activity or gene expression; Research reagents for pharmaceutical discovery or disease research, drug discovery or drug development; Chemical inducers of gene expression in plants, mammals, fungi and bacteria for industrial and agricultural applications; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
First Use Anywhere: 0
First Use in Commerce: 0
Class 005
Chemical preparations for medical and veterinary purposes, namely, chemical preparations for regulating, modifying, or restricting cellular activity or gene expression for purposes of treating diseases and genetic disorders; chemical preparations for antibody therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for therapeutic analysis; biochemical preparations for medical and veterinary purposes, namely, biochemical preparations for antibody therapy, for treating genetic disorders, and for use as medical and veterinary diagnostic reagents for antibody therapy analysis; Pharmaceutical preparations for modifying or regulating one or more cellular functions of mammals, fungi, plants, and bacteria and transgenic mammals, fungi, plants, and bacteria; transgenic plants, fungi and bacteria for medical and veterinary purposes; antibodies for use in disease testing; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
First Use Anywhere: 0
First Use in Commerce: 0
Class 040
Custom manufacturing and custom synthesis of antibodies and genetically engineered DNA expressing antibodies, biological organisms, cells, viruses, pathogens and special purpose cells to the specifications of others for scientific, research, medical, veterinary and laboratory use; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
First Use Anywhere: 0
First Use in Commerce: 0
Class 042
Development of new technology for others in the field of genetics, therapeutics and biotechnology; Development of products being antibodies and genetic therapies expressing antibodies to regulate, modulate, treat, prevent, and characterize disease states; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; Research and development services for others in the fields of biotechnology and antibody technology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells expressing antibodies for scientific, research, medical, veterinary and laboratory use; Scientific research and product development services for others in the pharmaceutical, biotechnology, biosensors, bioelectronics, medical and agriculture fields; Antibody technology and gene therapy services for others for product development and scientific research purposes, namely, antibody production, genetically engineering DNA expressing antibodies, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical, veterinary and laboratory use; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
First Use Anywhere: 0
First Use in Commerce: 0
Class 044
Medical services; Medical services, namely, antibody and gene therapy services; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
First Use Anywhere: 0
First Use in Commerce: 0
Class 045
Technology transfer services, namely, licensing and transfer of intellectual property; all of the foregoing featuring, including or involving monoclonal antibodies or portions thereof
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
001 005 040 042 044 045

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"MAB"